glp 1 approved for nash Full article: GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients Glucagon-like peptide 1 and fibroblast
Description
Better Health Store
Studies are demonstrating a plethora of positive effects on cardiovascular health, renal disease and liver disease, which may be directly related to the mitigation of the diabetes or obesity-associated risks of these complications or possibly direct protective effects
In turn, those SCFAs signal cells in the gut to release GLP-1 into the bloodstream
New research highlights the use of #GLP1 receptor agonists (like semaglutide &
Find out the right steps to take, when to take your next dose, and how to prevent gaps in your weight loss journey
